To confirm the effects of BRG1 on lymphangiogenesis in vivo, LoVo BRG1 knockdown or LoVo control cells (105 cancer cells per mouse) were injected subcutaneously into the mice, which were killed after 21 days. The gene discussed is SMARCA4; the disease is cancer.